Delivery Order SPE2DB22D1103-SPE2DB25FTNN3
Award Date
5/29/25
Potential Completion Date
6/20/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets over a performance period ending on May 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,283.14, is for the delivery of Envarsus XR 4 mg tablets. It is a firm fixed-price contract with a period of performance ending on May 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.66 firm fixed-price contract is for the supply of Envarsus XR 1 mg tablets, a specialty medication. The contract has a period of performance through February 25, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablet, a medication used in transplant patients. The contract has a firm fixed price, with a ceiling value of $5,135.85, and a performance period through June 5, 2025. The contract is not set aside and is open to full and open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $4,041.42 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,256,460 Envarsus XR 4 MG tablets. This contract supports medical supply requirements for government agencies and has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these prescription medications under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $1,216.11 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Envarsus XR 1 mg tablets. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, AmerisourceBergen provides a wide range of pharmaceutical products and medical supplies to support the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,841,195 units of the pharmaceutical product Envarsus XR 1 mg Tablet in 100-count packages. The delivery order has a firm fixed price of $1,621.48 and a completion date of October 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical supplies and medications to support various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablets, a specialized medication. The total ceiling value of the contract is $1,711.95, with a performance period ending on April 17, 2025. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a medication used for transplant recipients. The delivery order has a ceiling value of $1,288.86 and a completion date of June 11, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...